MIG
ABBV icon

McGuire Investment Group’s AbbVie ABBV Stock Holding History

McGuire Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,624
Closed -$242K – 116
2023
Q3 		$242K Hold
1,624
– – 0.05% 98
2023
Q2 		$219K Buy
1,624
+162
+11% +$23.8K 0.04% 106
2023
Q1 		$233K Buy
1,462
+32
+2% +$4.89K 0.05% 101
2022
Q4 		$231K Buy
+1,430
New +$219K 0.05% 104
2022
Q3 		– Sell
-1,507
Closed -$231K – 114
2022
Q2 		$231K Hold
1,507
– – 0.05% 103
2022
Q1 		$244K Buy
1,507
+17
+1% +$2.47K 0.04% 110
2021
Q4 		$202K Buy
+1,490
New +$176K 0.03% 118

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

McGuire Investment Group's ABBV Position: Q4 2023 in Review

McGuire Investment Group sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 1,624 shares — an estimated $242K sold.

McGuire Investment Group first reported a position in ABBV in Q4 2021 and held it in 7 quarters. The position peaked at $244K in Q1 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • McGuire Investment Group reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
  • McGuire Investment Group sold 1,624 AbbVie shares in Q4 2023, an estimated $242K.
  • McGuire Investment Group first reported a position in AbbVie in Q4 2021 and held it in 7 quarters.
  • McGuire Investment Group's AbbVie position peaked at $244K in Q1 2022.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on McGuire Investment Group's 13F filing for Q4 2023, filed 12 Jan 2024.